Share

cover art for The Companies and Markets Show: Insurers, weight-loss drugs and survivor shares

Investors' Chronicle

The Companies and Markets Show: Insurers, weight-loss drugs and survivor shares

This episode of The Companies and Markets Show begins with a dive into this week’s results from big players in the insurance industry, Aviva and Legal & General. Our deputy companies editor, Julian Hofmann, explains the market reaction to the businesses’ figures and highlights areas where they may be limited. Alex Newman joins to discuss what stands out for him and offers his take on the state of the insurers. 


Next up is a story that has sparked interest far and wide – weight-loss drugs. Jennifer Johnson explores what’s driven the surge in sales in recent months and highlights certain companies and sectors that may be affected by the growing popularity of appetite-suppressing drugs. 


Last on the agenda is our latest cover feature on survivor shares. Julian Hofmann discusses the companies that have withstood the test of time, and highlights the ingredients for long-term success.



More episodes

View all episodes

  • Best 50 ETFs, housebuilders & student Reits: The Companies and Markets Show

    39:10
    The episode begins with Alex discussing the housebuilding sector. He and Dan unpack Barratt’s (BDEV) recent trading update, whether investors should expect more M&A, and planning proposals from the new government.Julian follows up by analysing student accommodation provider Unite’s (UTG) seemingly positive trading update. He explores the investment case given the weakening relationship between international students and universities’ finances, and how planning changes could affect the sector.Last on the agenda is our annual ETF best-buy list. Dave Baxter explains the thinking behind the collection of funds, changes made for 2024, why investors should be wary of thematic ETFs and more. 1:30 Housebuilders 16:17 Unite 27:45 Top 50 ETFsClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.
  • Baltic Classifieds, ActiveOps & outsourcers: The Companies and Markets Show

    27:20
    We begin the show with Jemma Slingo who covers results at Baltic Classifieds (BCG), the largest internet services provider for the Baltics. The business has a dominant position in the housing and car listings market, making it a similar company to the UK’s Rightmove and Auto Trader. Dan and Jemma unpack its expansion plans, risks and valuation. Next, Mark Robinson joins to discuss the ‘decision intelligence’ company ActiveOps (AOM) which is gaining attention for high customer retention rates and positive earnings growth. Mark explores how large the scope is for its software services.Last up, Julian Hofmann and Jemma discuss outsourcers Serco (SRP) and Mitie (MTO). The two explore current trading at the two companies and their prospects under a Labour government. 1:22 Baltic Classifieds9:59 ActiveOps 20:18 Serco24:08 MitieClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.
  • 'We underestimated tech's potential': Alastair Laing of Capital Gearing Trust

    37:37
    Dave Baxter hosts Alastair Laing of Capital Gearing Trust, a vehicle which aims to grow but also protect investments over long periods. Often known for its bearish stance, the team at the trust use a combination of bonds, equities and property to position themselves and investors' cash securely in case of rocky market periods. In the episode, Dave and Alastair discuss how the trust has offset missing out on the US tech wave, inflation-linked bonds, the smaller positions they hold, and much more. Timestamps1:00 Positioning of the trust3:07 Pockets of value4:36 Drivers of a regime change5:57 Exposure to equities7:04 Offsetting lack of involvement of US gains 9:58 Bonds 13:12 Inflation-linked bonds 15:56 Executing investment views 18:25 Smaller positions20:31 Arriving at a valuation he can trust24:19 How the trust navigates investment trust investments27:09 Attitude to private equity 29:04 Share buybacks 34:07 The sector and structural decline Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.
  • Watches of Switzerland, Volex & CMC: The Companies and Markets Show

    26:58
    The Companies and Markets Show returns with a look at the prospects for three very different businesses. Retailer Watches of Switzerland (WOSG) had a disastrous start to the year but has shown signs of improvement since. Chris Akers asks if it can weather the luxury goods downturn.Then Jemma Slingo joins the show to examine Aim-listed cable and components maker Volex (VLX). Less glamorous it may be, but the latest figures demonstrate that the company has proved adept at diversifying its business despite destocking challenges. Lastly, Mark Robinson ponders the opportunities and risks facing one of the UK market’s best performers in 2024: trading platform CMC Markets (CMCX). Is there still value there for shareholders?Read our full analysis of the results hereWatches of Switzerland sticks with targets after tough yearVolex sales climb despite strong headwindsCMC's growth prospects supported by Revolut dealClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.
  • Young’s, conglomerates and the AI split: The Companies and Markets Show

    32:25
    The latest IC Companies and Markets podcast kicks off with a look at two pubcos hoping to benefit from an upturn in the weather and a summer of sport. Christopher Akers joins the show to examine recent results from Young’s (YNGN) and Fuller, Smith & Turner (FSTA) and asks what the future has in store.Jennifer Johnson then discusses this week’s IC cover story, on company spin-offs and the wider trend (or non-trend) of conglomerates breaking up. She runs the rule over companies in the pharmaceuticals, consumer goods and industrials sectors, and discusses whether divestments are creating or destroying value.Finally, in the week that Nvidia (US:NVDA) became the world’s largest company, Dave Baxter looks at the funds trying to exploit this trend. The team also discuss the growing imbalances in the US market – some of which are less obvious than you may think – and ask how much of a problem they really pose.Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.When corporate spin-offs work – and when they don'tFuller's to return more capital after strong yearYoung's biggest ever acquisition boosts revenuePunchy AI funds turn heads – but there are smarter ways to invest
  • We’re at the early stages of a UK equity surge: Guy Anderson of Mercantile Trust

    41:01
    Guy Anderson, fund manager of Mercantile Trust, joins Val Cipriani on the latest IC Interviews podcast. The trust is run by JP Morgan and is built on a bottom-up approach, focusing on quality UK mid-caps with strong cash flows that will accumulate dividends over time. In this episode, the two discuss the drivers behind the trust’s success and investment process, opportunities in the UK stock market, M&A activity and more. Timestamps00:58 UK mid-caps4:28 The UK stock market8:13 Red flags for gearing10:20 - The metrics that sound out when picking a stock 12:23 - Sectors that stand out and opportunities 15:20 - The risk of getting the recovery wrong 17:16 - 4imprint 20:44 Why exposure to housebuilders has gone up28:24 AI30:49 M&A activity 35:47 Dividends 38:02 The trust’s approach to discounts
  • Gold, election tax plans & Halma: The Companies and Markets Show

    34:05
    This week’s podcast begins with Alex Hamer discussing our latest cover feature on the rise of gold and to a lesser extent copper prices. Alex outlines the drivers of these price moves and highlights a variety of companies seeking to take advantage of these trends.Then, in a week when the biggest UK political parties all published their general election manifestos, Hermione Taylor asks what these pledges might mean for both the national and household finances.We conclude with a look at full-year results from safety equipment manufacturer Halma (HLMA). Mark Robinson asks whether another year of healthy growth has cemented its status as a quality UK share.Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.<boxout>Centrica: pay controversy and the energy transitionWhat stagnant bond yields mean for infrastructure trustsPrivate Investor's Diary: The UK market rally has much further to goWhy Britvic shares have plenty of fizz
  • Hollywood Bowl’s success & National Grid’s £7bn equity raise: The Companies and Markets Show

    35:20
    Jennifer Johnson begins this week’s podcast by discussing Hollywood Bowl’s (BOWL) results. Jennifer, Dan and Julian weigh in on the company’s successes and growth prospects, the factors underpinning its dividend prospects, and its current valuation case.National Grid (NG.) is next on the roster. Alex Hamer shares how the electricity giant surprised the market by securing the largest equity raise the London market has seen in almost a decade at £7bn. Alex and Dan discuss the rights issue’s importance for shareholders, what the money will be used for, and the impact the upcoming election will have on new grid investment. Last up, Dave Baxter dives into the latest apology from UK fund manager Nick Train on Finsbury Growth & Income's (FGT) shares lagging the FTSE All-Share. Dave and Dan discuss where the fund went wrong, the holdings it’s increasing exposure to and the prospects for the portfolio in general. Timestamps1:25 Hollywood Bowl (BOWL)14:28 National Grid (NG.)27:44 The latest apology from Nick TrainClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.
  • ‘We’re investors, we’re not supposed to mimic benchmarks’: Cathie Wood of Ark Invest

    52:03
    Known for her ‘active ETF’s’ enormous returns during the pandemic, thanks to big bets on the likes of Zoom and Tesla, Cathie Wood is synonymous with bold investing. But, while she has many accolades, her style and bold takes have not gone without criticism. The fund’s performance has been mixed, witnessing huge swings up and down since its inception, which some critics blame on her heavy reliance on instincts and poorly timed exits. In this episode, Dave Baxter and Cathie discuss those criticisms alongside the automated vehicle space in the US and China, digital wallet companies, and what it would take for Ark to buy more of the Magnificent 7.Timestamps 1:15 Tesla 9:05 How sensitive is the Innovation Fund to AI euphoria12:42 Risks in some of the stocks & Tesla’s risks in China15:18 Digital wallets ie. Coinbase & Robinhood20:24 Zoom23:57 The Magnificent 7 & what happens next29:46 Cathie’s take on inflation and interest rates31:53 How much politics is influencing stockpicks 34:11 The Innovation ETF’s focus on the US and looking further afield37:38  Merit to regulation39:04 Controversy around intellectual property and AI 41:58 Criticism of Ark’s approach and how the funds are run47:32 Poorly timed exits & NvidiaClaim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.